Join this webinar and learn how an integrated workflow that uses imaged capillary isoelectric focusing and UV/MS (icIEF-UV/MS) can help you with charge heterogeneity profiling challenges and hear from our customer from Astra Zeneca. Experience a disruptive approach that is changing the game for scientists pushing the next generation of biotherapeutics forward.

What you will learn:

  • Details on this integrated icIEF-UV/MS system
  • How this new strategy can make a difference in assessing the impact of cell culture conditions on monoclonal antibody (mAb) quality and production
  • The potential of using icIEF-UV/MS to characterize product quality attributes (PQAs) of complex biotherapeutics, including mAbs, antibody-drug conjugates (ADCs) and complex Fc fusion proteins

 

Agenda

09:00 - 09:05

Welcome

Maggie Ostrowski - Sr. Manager, CE-MS Product Management , SCIEX

09:05 - 09:35

Introduction to Intabio icIEF-UV 

Steven Calciano - Biopharma Business Development Manager, SCIEX

09:35 - 09:55

SCIEX 7600 ZenoTOF MS system

Justin Lim - Market Development Manager, SCIEX

 

09:55 - 10:25

A deep dive into the characterization of an ADC using an integrated icIEF-UV/MS system

Kristin Schultz-Kuszak - Associate Director, Astra Zeneca

10:25 – 10:30

Q&A

kosea-2023-intabio-launch-webinar-banner-2-825x430

Register to attend